Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis

The pharmacotherapy of cirrhosis: concerns and proposed investigations and solutions

(2016) M. B. Hilscher et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion

(2016) Rianne A Weersink et al.   BMJ Open

A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child–Pugh Classification

(2015) Julie Steelandt et al.   CLINICAL PHARMACOKINETICS

Review article: prescribing medications in patients with cirrhosis - a practical guide

(2013) J. H. Lewis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations

(2013) Carmen C. Franz et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Potentially inappropriate medication use among older adults in the USA in 2007

(2011) Yan-Jun Zhang et al.   AGE AND AGEING

Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis

(2011) Carmen C. Franz et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease

(2009) Chantal Schlatter et al.   DRUG SAFETY

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

(2008) Roger K. Verbeeck   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY